Steven Cohen’s Spero Therapeutics SPRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.7K Sell
14,639
-89,738
-86% -$122K ﹤0.01% 3811
2026
Q2
$231K Buy
104,377
+44,709
+75% +$117K ﹤0.01% 3481
2026
Q1
$140K Buy
59,668
+16,089
+37% +$38.2K ﹤0.01% 3577
2025
Q4
$102K Buy
+43,579
New +$101K ﹤0.01% 3739
2018
Q4
– Sell
-44,000
Closed -$462K – 1185
2018
Q3
$462K Buy
+44,000
New +$511K ﹤0.01% 932

Other funds holding SPRO

Steven Cohen's SPRO Position: Q3 2026 in Review

Steven Cohen reduced its Spero Therapeutics (SPRO) stake by 86% in Q3 2026, selling an estimated $122K and leaving 14,639 shares worth $17.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3811.

Steven Cohen first reported a position in SPRO in Q3 2018 and has held it in 5 quarters since. The position peaked at $462K in Q3 2018. 62 funds tracked by Wall St. Rank hold SPRO as of Q3 2026.

  • Steven Cohen held 14,639 shares of Spero Therapeutics worth $17.7K as of Q3 2026.
  • Steven Cohen sold 89,738 Spero Therapeutics shares in Q3 2026, an estimated $122K.
  • Spero Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3811 holding.
  • Steven Cohen first reported a position in Spero Therapeutics in Q3 2018 and has held it in 5 quarters since.
  • Steven Cohen's Spero Therapeutics position peaked at $462K in Q3 2018.
  • 62 funds tracked by Wall St. Rank held Spero Therapeutics as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.